Glycans Marker for Gastric Cancer
A team of researchers from the University of California Davis (California, USA) in collaboration with scientists in Mexico and South Korea have performed liquid chromatography–mass spectrometry (LC–MS) to find that sugars added to proteins could be an indicator of gastric cancer.
A team of researchers from the University of California Davis (California, USA) in collaboration with scientists in Mexico and South Korea have performed liquid chromatography–mass spectrometry (LC–MS) to find that sugars added to proteins could be an indicator of gastric cancer.
The study published in the journal Cancer Prevention Research suggests that glycans (sugars) found in blood serum could be a potential clinical biomarker. The disease kills approximately 700,000 people a year, largely affecting the population of Latin America, Asia, and Eastern Europe. The disease is often the result of a Helicobacter pylori infection, which can also result in asymptomatic gastritis and duodenal ulcers. However, there is no definitive test to determine whether or not the infection will lead to the onset of gastric cancer.
Glycans are added to proteins via the process of glycosylation, that is in a sense the postal service of the cell. The addition of glycans to a protein can be regulatory, in the case of an enzyme, or can act to direct it through the membrane transport system so that it reaches its target destination in the cell. This can be misregulated in some cancers, disrupting regular cell function.
The researchers were interested to learn if the level of glycans in blood serum varied between patients with gastritis, ulcers, or cancer. LC–MS was performed on 72 samples taken from patients in Mexico City. There were 19 significant changes in glycan levels, with three that could be used to differentiate between gastric cancer and gastritis.
Jay Solnick, lead author and professor at the Center for Comparative Medicine at UC Davis, said: “We showed statistically significant differences between the serum glycan profiles of patients with gastric cancer and those with gastritis.” He added: “This is the first time anyone has looked at whether serum glycans could be used to detect gastric cancer.” The next step for the researchers is to use this statistic difference to develop a diagnostic test. - —B.D.
DOI: 10.1158/1940-6207
This article first appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
